Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population

Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population

Bibliographic Details
Main Authors:	Martínez-Perez R, Muñoz-Jimenez A, Velloso-Feijoo M L, Rodríguez-Montero S, Hernández-Sánchez R, Uceda-Montañés J, Marenco J L
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	Journal of Translational Medicine

Similar Items

Juvenile idiopathic arthritis treated with biological therapies
by: Velloso Feijoo Maria, et al.
Published: (2012-11-01)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
by: Martínez-Pérez Rosalía, et al.
Published: (2011-11-01)

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
by: Martínez-Pérez Rosalía, et al.
Published: (2012-11-01)

Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis
by: Martínez-Pérez Rosalia, et al.
Published: (2011-11-01)

Prediction of treatment response by anticitrullinated protein antibodies (ACPA) levels among patients with rheumatoid arthritis
by: Hernández Raquel, et al.
Published: (2012-11-01)

Psychometric validation of an empowerment scale for Spanish-speaking patients with rheumatoid arthritis
by: Irazú Contreras-Yáñez, et al.
Published: (2018-10-01)

Wegener granulomatosis: type of presentation and initial treatment in a series of 23 cases
by: Martínez-Pérez Rosalia, et al.
Published: (2012-11-01)

Biologic monotherapy in the treatment of rheumatoid arthritis
by: Detert J, et al.
Published: (2015-05-01)

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
by: Mahlich J, et al.
Published: (2016-08-01)

The AIRE gene and susceptibility to rheumatoid arthritis in the Spanish population
by: Torres Belen, et al.
Published: (2011-11-01)

Biologic therapy of rheumatoid arthritis
by: Damjanov Nemanja, et al.
Published: (2009-01-01)

Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients.
by: Laura Vidal-Bralo, et al.
Published: (2017-01-01)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
by: Findeisen KE, et al.
Published: (2021-08-01)

The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods
by: Uceda Julia, et al.
Published: (2012-11-01)

IMPACT OF BIOLOGICAL THERAPY ON BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: P. S. Dydykina, et al.
Published: (2014-12-01)

Cardiovascular risk and mannose binding lectin in patients with rheumatoid arthritis from southern Brazil
by: Barbara S. Kahlow, et al.
Published: (2018-09-01)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
by: Victoria Furer, et al.
Published: (2023-04-01)

Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy
by: Jennifer L Barton
Published: (2009-11-01)

Safety of using genetic engineering biological agents in rheumatoid arthritis
by: N V Chichasova, et al.
Published: (2010-03-01)

Role of biological agents in treatment of rheumatoid arthritis
by: Law, S, et al.
Published: (2019)

Biological agents in monotherapy for the treatment of rheumatoid arthritis
by: Cem Gabay, et al.
Published: (2014-04-01)

Bone Effects of Biologic Drugs in Rheumatoid Arthritis
by: Addolorata Corrado, et al.
Published: (2013-01-01)

Biologics for rheumatoid arthritis: an overview of Cochrane reviews
by: Jasvinder A. Singh, et al.

Scleritis in rheumatoid arthritis: Before and during biologic era
by: Daphne P. C. Vergouwen, et al.
Published: (2023-01-01)

Rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1996)

Rheumatoid arthritis or parvovirus B19 arthritis?
by: J. de Carvalho, et al.
Published: (2021-09-01)

Repeatability and Reliability of the Rheumatoid Arthritis Foot Disease Activity Index in Spanish Patients: A Transcultural Adaptation
by: Eva María Martínez-Jiménez, et al.
Published: (2021-12-01)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
by: López Longo J, et al.
Published: (2010-11-01)

Rheumatology: Rheumatoid Arthritis
by: José Elías GARCÍA SÁNCHEZ, et al.
Published: (2017-03-01)

The subgingival microbiomes in periodontitis and health of individuals with rheumatoid arthritis and at risk of developing rheumatoid arthritis
by: Z. Cheng, et al.
Published: (2017-05-01)

Inhibitor of biological effects of interleukin-6 sarilumab in treatment of rheumatoid arthritis
by: D. E. Karateev, et al.
Published: (2019-12-01)

Immunotherapy for rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2001)

Nimesulide in rheumatoid arthritis
by: E. L. Luchikhina
Published: (2015-06-01)

Biologics in rheumatoid arthritis (RA) – recommendations for Swiss practice
by: BA Michel
Published: (2011-05-01)

Interstitial Lung Disease in Rheumatoid Arthritis in the Era of Biologics
by: A. Picchianti Diamanti, et al.
Published: (2011-01-01)

Predictors of Remission in Rheumatoid Arthritis Patients Treated with Biologics:
by: Yasmin Khader
Published: (2023-05-01)

Models of rheumatoid arthritis.
by: Williams, R
Published: (2005)

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
by: Deighton, C, et al.
Published: (2010)

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
by: Deighton, C, et al.
Published: (2010)

USE OF GENETICALLY ENGINEERED BIOLOGICAL DRUGS FOR RHEUMATOID ARTHRITIS IN THE RUSSIAN FEDERATION
by: Rimma Mikhailovna Balabanova, et al.
Published: (2012-12-01)